TX
TherapeuticsMD, Inc.
TXMD · NASDAQ
$2.19 +0.23% (+$0.01)
1M +5.80%
Market Cap $25.3M
P/E Ratio -
Div. Yield -
ROE 0.80%
Piotroski F-Score Moderate
4/9Valuation
79 /100
Cheap P/B 0.93x
P/FCF 8.12x
P/S 7.75x
Growth
0 /100
Declining Book val. growth 8.55%
Rev. growth 64.91%
FCF growth N/A
Profitability
50 /100
Moderate Net margin 6.64%
Op. margin 118.20%
FCF margin 95.41%
Quality
2 /100
Poor ROE 0.80%
ROA 0.58%
Asset turnover 0.09x
Debt
69 /100
Low Current ratio 3.22x
Int. coverage -1,405.25x
Debt/Equity 0.20x
Stability
56 /100
Moderate Rev. volatility 89.38%
EPS volatility 10.76%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TXMD
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marlan D. Walker
Employees
1
Headquarters
Boca Raton
Evenimente viitoare
17 NOV.
Earnings
Upcoming earnings report